跳转至内容
Merck
CN

59353-U

Supelco

Discovery® C8 (5 µm) HPLC Columns

L × I.D. 15 cm × 4.6 mm, HPLC Column

别名:

C8 Reversed-Phase Chromatography Column

登录查看公司和协议定价


About This Item

UNSPSC代码:
41115700
eCl@ss:
32110501
NACRES:
SB.52

产品名称

Discovery ® C8 HPLC 色谱柱, 5 μm particle size, L × I.D. 15 cm × 4.6 mm

物料

stainless steel column

质量水平

Agency

suitable for USP L7

产品线

Discovery®

特点

endcapped

制造商/商品名称

Discovery®

包装

1 ea of

标记范围

7.5% Carbon loading

参数

≤70 °C temp. range
400 bar pressure (5801 psi)

技术

HPLC: suitable
LC/MS: suitable

长度 × 内径

15 cm × 4.6 mm

表面积

200 m2/g

表面覆盖度

3.4 μmol/m2

杂质

<10 ppm metals

基质

silica gel, high purity, spherical base material
fully porous particle

基质活性基团

C8 (octyl) phase

粒径

5 μm

孔径

180 Å

工作pH范围

2-8

应用

food and beverages

分离技术

reversed phase

正在寻找类似产品? 访问 产品对比指南

应用

Discovery® C8 HPLC色谱柱已用于使用反相高效液相色谱(RP-HPLC)分离片剂中的氟喹诺酮类抗生素。

特点和优势

  • 优良的重现性。
  • 分析强疏水性化合物时比 C18 柱快
  • 稳定性好、低流失,适用于 LC-MS 分析
  • 分析碱性和酸性化合物均可获得良好峰形
  • 可兼容低有机溶剂/高含水量的流动相

法律信息

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hugo M Botelho et al.
Scientific reports, 5, 9038-9038 (2015-03-13)
Plasma membrane proteins are essential molecules in the cell which mediate interactions with the exterior milieu, thus representing key drug targets for present pharma. Not surprisingly, protein traffic disorders include a large range of diseases sharing the common mechanism of
M Q Zhang et al.
Die Pharmazie, 46(10), 687-700 (1991-10-01)
The rapid growth in the quinolone research changed the whole face of the previous SAR concepts. So far structural modifications at all positions of the quinolone nucleus except the 4-oxo group have successfully lead to the discovery of potent antimicrobial
G L Bundy et al.
The Journal of biological chemistry, 261(2), 747-751 (1986-01-15)
The gorgonian coral Pseudoplexaura porosa contains a lipoxygenase capable of converting exogenous arachidonic acid into (8R)-8-hydroperoxy-5,9,11,14-eicosatetraenoic acid. The (8R)- (or 8-L-) configuration in this product, opposite to that observed in previously reported 8-lipoxygenase products, was determined unambiguously by comparison of
Simeon Grazio et al.
Clinical and experimental rheumatology, 31(5), 665-671 (2013-06-07)
Using proteomic approach in this study, we sought to identify proteins with heparin affinity associated with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and non-inflammatory arthritis (NIA). Plasma samples from adult RA, PsA and NIA patients, 20 of each, were collected.
Scott C Bell et al.
Pharmacology & therapeutics, 145, 19-34 (2014-06-17)
With the discovery of the CFTR gene in 1989, the search for therapies to improve the basic defects of cystic fibrosis (CF) commenced. Pharmacological manipulation provides the opportunity to enhance CF transmembrane conductance regulator (CFTR) protein synthesis and/or function. CFTR

实验方案

Separations of Tetracycline Antibiotics by Reversed Phase HPLC, Using Discovery Columns

相关内容

Discovery C18 and C8 HPLC Columns products offered

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门